The DOI matches its Crossref record; 29 of the 30 references it cites were found in a registry or an index.
The pathological response to DNA damage does not contribute to p53-mediated tumour suppression
Abstract
The p53 protein has a highly evolutionarily conserved role in metazoans as 'guardian of the genome', mediating cell-cycle arrest and apoptosis in response to genotoxic injury. In large, long-lived animals with substantial somatic regenerative capacity, such as vertebrates, p53 is an important tumour suppressor--an attribute thought to stem directly from its induction of death or arrest in mutant cells with damaged or unstable genomes. Chemotherapy and radiation exposure both induce widespread p53-dependent DNA damage. This triggers potentially lethal pathologies that are generally deemed an unfortunate but unavoidable consequence of the role p53 has in tumour suppression. Here we show, using a mouse model in which p53 status can be reversibly switched in vivo between functional and inactive states, that the p53-mediated pathological response to whole-body irradiation, a prototypical genotoxic carcinogen, is irrelevant for suppression of radiation-induced lymphoma. In contrast, delaying the restoration of p53 function until the acute radiation response has subsided abrogates all of the radiation-induced pathology yet preserves much of the protection from lymphoma. Such protection is absolutely dependent on p19(ARF)--a tumour suppressor induced not by DNA damage, but by oncogenic disruption of the cell cycle.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although the p53-mediated DNA damage response appears not to be part of p53’s function as tumor suppressor,164 it does support cell viability.”
From Census and evaluation of p53 target genes (2017) · cites this paper as [164]
Citations
Cites
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Lane, D. P. (1992) · Nature · doi:10.1038/358015a0 · Cited by 5,138
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
Bartkova, J., Hořejší, Z., Koed, K., Krämer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J. M., Lukas, C., et al. (2005) · Nature · doi:10.1038/nature03482 · Cited by 2,688
Tumor spectrum analysis in p53-mutant mice
Jacks, T., Remington, L., Williams, B. O., Schmitt, E. M., Halachmi, S., Bronson, R. T., & Weinberg, R. A. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00002-6 · Cited by 2,051
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions
Gorgoulis, V. G., Vassiliou, L.-V. F., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., DiTullio, R. A., Kastrinakis, N. G., Levy, B., et al. (2005) · Nature · doi:10.1038/nature03485 · Cited by 2,009
Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19
Kamijo, T., Zindy, F., Roussel, M. F., Quelle, D. E., Downing, J. R., Ashmun, R. A., Grosveld, G., & Sherr, C. J. (1997) · Cell · doi:10.1016/s0092-8674(00)80452-3 · Cited by 1,566
Ouelle, D. E., Zindy, F., Ashmun, R. A., & Sherr, C. J. (1995) · Cell · doi:10.1016/0092-8674(95)90214-7 · Cited by 1,485
Lowe, S. W., Cepero, E., & Evan, G. I. (2004) · Nature · doi:10.1038/nature03098 · Cited by 1,374
Self-citationMyc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization
Zindy, F., Eischen, C. M., Randle, D. H., Kamijo, T., Cleveland, J. L., Sherr, C. J., & Roussel, M. F. (1998) · Genes & Development · doi:10.1101/gad.12.15.2424 · Cited by 1,245
Flagged first, then by citations
1 of the 30 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 301–382 of 382
ARF suppresses hepatic vascular neoplasia in a carcinogen‐exposed murine model
Busch, S., Gurley, K. E., Moser, R. D., & Kemp, C. J. (2012) · The Journal of Pathology · doi:10.1002/path.4024 · Cited by 10
Estrogens Counteract Platinum-Chemosensitivity by Modifying the Subcellular Localization of MDM4
Lucà, R., di Blasio, G., Gallo, D., Monteleone, V., Manni, I., Fici, L., Buttarelli, M., Ciolli, G., Pellegrino, M., Teveroni, E., et al. (2019) · Cancers · doi:10.3390/cancers11091349 · Cited by 8
Protective Effects of p53 Regulatory Agents Against High-LET Radiation-Induced Injury in Mice
Morita, A., Wang, B., Tanaka, K., Katsube, T., Murakami, M., Shimokawa, T., Nishiyama, Y., Ochi, S., Satoh, H., Nenoi, M., et al. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.601124 · Cited by 8
Reed, S. M., Hagen, J., Muniz, V. P., Rosean, T. R., Borcherding, N. C., Sciegienka, S. J., Goeken, J. A., Naumann, P. W., Zhang, W., Tompkins, V. S., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112126 · Cited by 8
Yoshida, K., Hirabayashi, Y., Wada, S., Watanabe, F., Watanabe, K. S., Aizawa, S., & Inoue, T. (2007) · Radiation Research · doi:10.1667/rr0820.1 · Cited by 8
The pathogenesis of therapy-related myeloid neoplasms from TP53-mutant clonal hematopoiesis
Fullin, J., Topçu, E., Zielińska, K. A., Schimmer, R. R., Klemm, N., Koch, C., Caiado, F., Lock, M., Doerdelmann, C., Bühler, M. M., et al. (2025) · Leukemia · doi:10.1038/s41375-025-02839-5 · Cited by 9
Hasapis, S., Caraballo, I., Sears, T. J., Brock, K. D., Cart, J. B., Moding, E. J., & Lee, C. (2023) · Scientific Reports · doi:10.1038/s41598-023-39678-2 · Cited by 7
Marney, C. B., Anderson, E. S., Baum, R., & Schmitt, A. M. (2022) · Cells · doi:10.3390/cells11111818 · Cited by 7
Adams, C., Yu, J. S., Mao, J., Jen, K., Costes, S. V., Wade, M. R., Shoemake, J. D., Aina, O. H., Rosario, R. D., Menchavez, P. T., et al. (2015) · Molecular Carcinogenesis · doi:10.1002/mc.22377 · Cited by 7
Teroxirone inhibited growth of human non-small cell lung cancer cells by activating p53
Wang, J.-P., Lin, K.-H., Liu, C., Yu, Y.-C., Wu, P.-T., Chiu, C., Su, C., Chen, K.-M., & Fang, K. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.08.007 · Cited by 7
Sustained p16INK4a expression is required to prevent IR-induced tumorigenesis in mice
Palacio, L., Krishnan, V., Le, N. L. O., Sharpless, N. E., & Beausejour, C. M. (2016) · Oncogene · doi:10.1038/onc.2016.298 · Cited by 7
Defining key concepts of intestinal and epithelial cancer biology through the use of mouse models
Phesse, T. J., Durban, V. M., & Sansom, O. J. (2017) · Carcinogenesis · doi:10.1093/carcin/bgx080 · Cited by 7
Genetic Mouse Models of Cancer
Winslow, M. M., & Jacks, T. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4066-6.00009-3 · Cited by 7
Muddineni, S. S. N. A., Katz-Even, C., Zipin‐Roitman, A., Rasoulouniriana, D., Roy, D. S., Aborgies, R., Beider, K., Raz, Y., Solomon, N., Hershkovitz, G., et al. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-08502-w · Cited by 6
Chk2 Protects against Radiation-Induced Genomic Instability
MacLaren, A., Slavin, D. A., & McGowan, C. H. (2009) · Radiation Research · doi:10.1667/rr1603.1 · Cited by 6
The Ever-Lengthening Arm of p53
Evan, G. I. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.07.012 · Cited by 6
Self-citationChemical induced alterations in p53 signaling
Högberg, J., Silins, I., & Stenius, U. (2009) · Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions · doi:10.1007/978-3-7643-8336-7_7 · Cited by 6
Apoptosis: Signaling Pathways in Pancreatic Cancer Pathogenesis
McConkey, D. J., & Choi, W. (2018) · Springer eBooks · doi:10.1007/978-1-4939-7193-0_14 · Cited by 5
Báječný, M., Chen, C., Faltusová, K., Heizer, T., Szikszai, K., Páral, P., Šefc, L., & Nečas, E. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.660617 · Cited by 5
The DNA Damage Response Mediates Apoptosis and Tumor Suppression
Baran, K., Rodríguez, D. A., & Green, D. R. (2013) · Springer eBooks · doi:10.1007/978-1-4614-9302-0_7 · Cited by 6
Senescence Associated Heterochromatic Foci: SAHF
Chandra, T. (2016) · Springer eBooks · doi:10.1007/978-3-319-38882-3_9 · Cited by 7
Hagen, J., Tompkins, V. S., Dudakovic, A., Weydert, J. A., & Quelle, D. E. (2008) · Hybridoma · doi:10.1089/hyb.2007.0533 · Cited by 4
Development of p53-targeting drugs that increase radioresistance in normal tissues
Ochi, S., Nishiyama, Y., & Morita, A. (2019) · The Journal of Medical Investigation · doi:10.2152/jmi.66.219 · Cited by 4
Killer, K., Lê, O., & Beausejour, C. M. (2021) · Radiation Research · doi:10.1667/rade-21-00017.1 · Cited by 4
[P53 and its role in the ovarian surface epithelium. A review].
Chuaire, L., Sánchez, M. C., & Ramírez-Clavijo, S. R. (2008) · PubMed · Cited by 4
Кашеварова, А. А., Tolmacheva, E. N., Sukhanova, N. N., Sazhenova, E. A., & Лебедев, И. Н. (2009) · Russian Journal of Genetics · doi:10.1134/s1022795409060155 · Cited by 4
Quelle, D. E., Nteeba, J., & Darbro, B. W. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-394447-4.30060-8 · Cited by 4
Paradoxical Puma Prohibits Pyruvate Pumps to Prime Pathology
Green, D. R. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.01.016 · Cited by 3
Campisi, J. (2011) · Developmental Cell · doi:10.1016/j.devcel.2011.04.015 · Cited by 4
Sage, J., Attardi, L. D., & Dyke, T. V. (2011) · Springer eBooks · doi:10.1007/978-0-387-69805-2_14 · Cited by 3
Characterization of the E3 Ubiquitin Ligase Pirh2
Tai, E. (2010) · TSpace (University of Toronto) · Cited by 3
Nucleolar Signaling Determines Cell Fate: The RP-Mdm2-p53 Axis Fine-Tunes Cellular Homeostasis
Liu, Y., & Zhang, Y. (2013) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-1-4614-8039-6_9 · Cited by 2
Aoki, S., Ariyasu, S., Hanaya, K., Hisamatsu, Y., & Sugai, T. (2016) · Journal of Synthetic Organic Chemistry Japan · doi:10.5059/yukigoseikyokaishi.74.482 · Cited by 2
The p53-Mdm2 Loop: A Critical Juncture of Stress Response
Levav-Cohen, Y., Goldberg, Z., Alsheich-Bartok, O., Zuckerman, V., Haupt, S., & Haupt, Y. (2010) · Molecular biology intelligence unit · doi:10.1007/978-1-4419-8231-5_5 · Cited by 2
Apoptosis Signaling Pathways in Pancreatic Cancer Pathogenesis
McConkey, D. J. (2009) · Springer eBooks · doi:10.1007/978-0-387-77498-5_14 · Cited by 2
Intestinal homeostasis and neoplasia studied using conditional transgenesis
Marsh, V. L., & Clarke, A. R. (2007) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.7.4.519 · Cited by 2
Ali, G., & Ahmed, B. (2023) · Egyptian Journal of Veterinary Science · doi:10.21608/ejvs.2023.205434.1490 · Cited by 1
Development and Validation of a 7-eRNA Prognostic Signature for Lung Adenocarcinoma
Sun, Y., Chen, K., Zhang, J., Hu, Z., Xiong, M., Fang, Z., Chen, G., Meng, X., Liao, B., Xiong, Y., et al. (2025) · Biology · doi:10.3390/biology14101431 · Cited by 1
Berberine alleviates radiation-induced intestinal injury by inhibiting cellular senescence
Niu, X., Ren, Z., Deng, L., Yang, S., Gao, J., Bi, C., Wang, R., Sun, S., Chen, A., Li, Q., et al. (2026) · Radiation Oncology · doi:10.1186/s13014-026-02851-8 · Cited by 1
Saito, M., Nakasuka, F., Sankoda, N., Wang, Y., Taguchi, J., Ohta, S., Yamada, Y., Ozawa, M., Sakurai, S., Kondo, A., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-74929-6 · Cited by 1
Gan, Q., Li, W., Lex, R. K., Ying, Z., & Beronja, S. (2026) · Science · doi:10.1126/science.aed3065 · Cited by 1
Genetic Mouse Models of Cancer
Winslow, M. M., & Jacks, T. (2008) · Elsevier eBooks · doi:10.1016/b978-141603703-3.10009-3 · Cited by 1
OxPhos Defects and Their Role in Cancer Initiation and Progression
Yadava, N., Khalil, A., & Schneider, S. S. (2013) · Springer eBooks · doi:10.1007/978-1-4614-9326-6_1 · Cited by 1
Design, synthesis and biological evaluation of 2-pyrrolone derivatives as radioprotectors
Satoh, H., Ochi, S., Mizuno, K., Saga, Y., Ujita, S., Toyoda, M., Nishiyama, Y., Tada, K., Matsushita, Y., Deguchi, Y., et al. (2022) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2022.116764 · Cited by 1
p53 Inhibitors as Cancer Sensitizing Agents
Maina, F., & Dono, R. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-474-2_12 · Cited by 1
McCarthy, N. J. (2006) · Nature reviews. Cancer · doi:10.1038/nrc2000 · Cited by 1
Role of Jun dimerization protein 2 (JDP2) in cellular senescence
Huang, Y., Lee, I.-L., Tsai, Y.-F., Saito, S., Lin, Y., Chiou, S., Tsai, E., & Yokoyama, K. K. (2010) · Inflammation and Regeneration · doi:10.2492/inflammregen.30.507 · Cited by 1
DNA Damage Response Suppresses Epstein-Barr Virus-Driven Proliferation of Primary Human B Cells
Nikitin, P. A. (2012) · DukeSpace (Duke University)
Velasco-Hernández, T. (2011) · Gredos (University of Salamanca) · doi:10.14201/gredos.110634
Modulation of p53 activities by the prolyl-isomerase PIN1 and the bromodomain protein BRD7
Tocco, F. (2008) · OpenstarTs (Univeristy of Trieste https://www.units.it/)
The regulation of RNA polymerase III-mediated transcription by p53, AP-1 and JNKs
Dowding, S. N. (2013) · Enlighten: Theses (The University of Glasgow)
Molecular mechanisms of growth suppression by pharmacologically activated p53
Hedström, E. (2009) · Figshare
Vanadate:A Novel Type of Radioprotector Acts by Inhibiting p53.
Morita, A., Yamamoto, S., Ikekita, M., Wang, B., & Tanaka, K. (2010) · RADIOISOTOPES · doi:10.3769/radioisotopes.59.459
Epigenetic regulation of p16 Ink4a and Arf by JDP2 in cellular senescence
Nakade, K., Wasylyk, B., & Yokoyama, K. K. (2010) · BioMolecular Concepts · doi:10.1515/bmc.2010.008
Chen, C. S., Xiao, F., Xu, S. W., Tao, F., Shi, X., Liu, R. G., Dong, X. Z., & Fu, F. (2011) · Advanced materials research · doi:10.4028/www.scientific.net/amr.340.439
Tuning the body's defence to cancer
Heady, L. (2006) · Nature · doi:10.1038/news060904-8
An oncogene-induced DNA replication stress model for human cancer development
Halazonetis, T. D., Zgheib, O., Gorgoulis, V. G., & Bártek, J. (2008) · European Journal of Cancer Supplements · doi:10.1016/s1359-6349(08)71417-4
The p53 homolog p63 modulates acute and chronic damage in irradiated salivary glands
Mitchell, G. C. (2010) · UA Campus Repository (The University of Arizona)
Chang, S. S. (2007) · Springer eBooks · doi:10.1007/978-3-540-73709-4_4
Stress and cellular aging Associations between stress-related factors and leukocyte telomere length
Savolainen, K. (2016) · Työväentutkimus Vuosikirja
Malaquin, N., Carrier-Leclerc, A., Martinez, A., Dessureault, M., Ghadaouia, S., Coppé, J., Nadeau, S., Cardin, G. B., Campisi, J., & Rodier, F. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/413732
Genetically Engineered Mouse Models for Studying Radiation Biology and Radiosensitizers
Floyd, W., Kuo, H.-C., Himes, J. E., Patel, R., & Kirsch, D. G. (2020) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-030-49701-9_8
Long-term p21 and p53 trends regulate the frequency of mitosis events and cell cycle arrestPreprint
Tran, A. P., Tralie, C. J., Moosmüller, C., Belkhatir, Z., Reyes, J. S., Levine, A. J., Deasy, J. O., & Tannenbaum, A. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.08.17.456721
Homologs of the Tumor Suppressor Protein p53: A Bioinformatics Study for Drug Design.
Thayer, K. M., & Carcamo, C. (2020) · PubMed
Redox regulation of the tumor suppressor p53
Shi, T. (2021) · Utrecht University Repository (Utrecht University) · doi:10.33540/966
A Novel Intramolecular Interaction in P53
He, F. (2020) · Digital Commons - University of South Florida (University of South Florida)
An Oncogene-Induced DNA Replication Stress Model for Cancer Development
Halazonetis, T. D. (2009) · Springer eBooks · doi:10.1007/978-90-481-2561-6_3
Rosell, R. (2012) · doi:10.2217/ebo.12.2
Quelle, D. E., Nteeba, J., & Darbro, B. W. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-821618-7.30060-8
Data from Mouse Models for the p53 R72P Polymorphism Mimic Human Phenotypes
Zhu, F., Dollé, M. E. T., Berton, T. R., Kuiper, R., Capps, C., Espejo, A. B., McArthur, M. J., Bedford, M. T., STEEG, H. V., de Vries, A., et al. (2023) · doi:10.1158/0008-5472.c.6501141.v1
Ali, G. S. (2023) · Asian Pacific Journal of Cancer Biology · doi:10.31557/apjcb.2023.8.1.63-68
Liu, G., Li, W., Wang, H., Su, W., & Zou, J. (2026) · Medicine · doi:10.1097/md.0000000000049400
DNA damage recognition in the normal epithelium of human prostate and seminal vesicles
Jäämaa, S. (2011) · Työväentutkimus Vuosikirja
The p53 Master Regulator and Rules of Engagement with Target Sequences
Inga, A., Jordan, J. J., Menéndez, D., Sanctis, V. D., & Resnick, M. A. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374145-5.00265-5
Metadata
- Authors
- Christophorou, M. A., Ringshausen, I., Finch, A. J., Swigart, L. B., & Evan, G. I.
- Affiliations
- University of California, San Francisco (US)
- Corresponding author
- Evan, G. I.
- Venue
- Nature
- Published
- 2006-09
- Volume
- 443
- Issue
- 7108
- Pages
- 214-217
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1970249544
- Cited by
- 382
- References
- 30
- Citations by year
- 2026: 6 · 2025: 2 · 2024: 3 · 2023: 10 · 2022: 6 · 2021: 13 · 2020: 11 · 2019: 8 · 2018: 5 · 2017: 17 · 2016: 19 · 2015: 19 · 2014: 26 · 2013: 24 · 2012: 23
- FWCI
- 21.50
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Funders
- University of California, San Francisco
- National Institute on Aging
- National Cancer Institute
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Keywords
- p53, tumor suppression, DNA damage response, radiation-induced lymphoma, whole-body irradiation, ARF, oncogene activation, cell cycle arrest, apoptosis, lymphomagenesis
- MeSH terms
- Animals, DNA Damage, Lymphoma, Neoplasms, Radiation-Induced, Tumor Suppressor Protein p53, Cyclin-Dependent Kinase Inhibitor p16, Tumor Suppressor Protein p14ARF, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review